The Archive includes the ADA Report (2006), Methamphetamine in Missouri (2004), MDMA in Missouri (2002), OxyContin in Missouri (2002), and Prevention Needs Assessment (2002).
The report Alcohol, Drug and Tobacco Use in Missouri: A Profile in Prevention and Treatment - 2006 provides data that illustrates the prevalence of–-and trends in–-alcohol, drug and tobacco use and abuse in Missouri. When possible, Missouri data are compared to national prevalences and trends. Additionally, this report presents data on the costs and consequences of substance use and abuse in Missouri. NOTE: If you wish to print this document, change your settings to be in landscape orientation and double-sided printing.
Methamphetamine in Missouri 2004 was prepared by the Missouri Institute of Mental Health under the direction of the Division of Alcohol and Drug Abuse. The brief describes methamphetamine manufacturing and trafficking, physiological reactions, and health consequences associated with its use. It also includes both state and national epidemiological data describing the prevalence of methamphetamine use as reported by the Community Epidemiology Work Group.
This policy brief discusses the history of methylenedioxymethamphetamine (MDMA), often referred to as Ecstasy, its relationship to other drugs, its manufacturing and trafficking, and the physiological reactions and health consequences associated with its use. A review of national and Missouri epidemiological data describes the prevalence and patterns of its use. Recommendations for treatment, prevention, and policy are also discussed. Finally, resources for additional study are provided.
The purpose of this policy brief is to describe what is currently known about OxyContin, report available national and local data on OxyContin abuse, and present ideas for effective prevention and treatment of OxyContin abuse in Missouri. Some of the communities experiencing significant problems with OxyContin, such as Hazard, Kentucky, and Pulaski, Virginia, are similar in demographic and geographic terms to Missouri communities. Also, there is some evidence that abuse of OxyContin is becoming a trend in America's heartland. For these reasons, it is important that Missouri examine the prevention and interdiction models developed by neighboring states and respond proactively to this emerging problem.
Missouri Substance Abuse Prevention Needs Assessment Studies
Beginning in 1999, the Department of Mental Health, Division of Alcohol and Drug Abuse, under the direction of the Center for Substance Abuse Prevention (CSAP), conducted a formal assessment of Missouri's prevention needs. The Prevention Needs Assessment consisted of four research-based studies, each with a specific focus and objective. The purpose of the studies was to provide a framework of data and procedures and assist prevention planners and policy makers to identify high-risk populations, select appropriate prevention strategies, and assess the effectiveness of program implementation.
This study was designed to make use of existing and readily available data at the county level for the purpose of characterizing substance abuse levels and risk factors for substance abuse for each Missouri county. Most data were collected for a five-year period from 1995-1999. In addition to the county data reported in Study 2, risk profiles derived from the data were developed for each county. These profiles are accessible on the county data pages through the ADA interactive map: County Map
Study 4: Integrative Findings from the Missouri Substance Abuse Prevention Needs Assessment Project (2002)
This report integrates data and findings from the 2000 school survey and the Social Indicators report. The purpose of this study was to promote the use of research-based prevention by applying empirical data and utilizing state-of-the-art technology to examine the geographic distribution of substance use, risk factors, and other indicators associated with high risk communities.